Reply to: Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies".
作者信息
Kregting Lindy M, Sankatsing Valérie D V, Heijnsdijk Eveline A M, de Koning Harry J, van Ravesteyn Nicolien T
机构信息
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
出版信息
Int J Cancer. 2022 Aug 15;151(4):651-652. doi: 10.1002/ijc.34042. Epub 2022 May 6.
Abstract
摘要
相似文献
1
Reply to: Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies".回复：关于“寻找最佳乳腺钼靶筛查策略：920种模拟策略的成本效益分析”的评论
Int J Cancer. 2022 Aug 15;151(4):651-652. doi: 10.1002/ijc.34042. Epub 2022 May 6.
2
Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies".关于《寻找最佳乳腺钼靶筛查策略：920种模拟策略的成本效益分析》的评论
Int J Cancer. 2022 Aug 15;151(4):649-650. doi: 10.1002/ijc.34043. Epub 2022 May 6.
3
Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modelled strategies.寻找最佳的乳腺 X 光筛查策略：对 920 种模型策略的成本效益分析。
Int J Cancer. 2022 Jul 15;151(2):287-296. doi: 10.1002/ijc.34000. Epub 2022 Mar 21.
4
Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.评估针对一般风险女性的更新乳腺癌筛查指南的成本效益。
Value Health. 2019 Feb;22(2):185-193. doi: 10.1016/j.jval.2018.07.880. Epub 2018 Sep 8.
5
Total cost-effectiveness of mammography screening strategies.乳腺钼靶筛查策略的总体成本效益
Health Rep. 2015 Dec;26(12):16-25.
6
Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program.在全国性乳腺癌筛查计划中，对乳腺致密的女性进行简化协议 MRI 筛查的成本效益。
Breast. 2022 Feb;61:58-65. doi: 10.1016/j.breast.2021.12.004. Epub 2021 Dec 10.
7
Reply to Opportunity cost of annual screening mammography.对年度乳腺钼靶筛查的机会成本的回复。
Cancer. 2018 Mar 15;124(6):1298-1299. doi: 10.1002/cncr.31195. Epub 2017 Dec 19.
8
Mammography screening for breast cancer.乳腺癌的乳腺钼靶筛查。
Maturitas. 2010 Aug;66(4):435. doi: 10.1016/j.maturitas.2010.05.007. Epub 2010 Jun 11.
9
The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.数字乳腺断层合成在人群乳腺癌筛查计划中的成本效益。
Eur Radiol. 2020 Oct;30(10):5437-5445. doi: 10.1007/s00330-020-06812-x. Epub 2020 May 7.
10
Women aged 75 years and older benefit from mammography.75岁及以上的女性从乳房X光检查中受益。
Cancer. 2015 Jan 15;121(2):165. doi: 10.1002/cncr.29219.
引用本文的文献
1
Modeling optimal combination of breast and cervical cancer screening strategies in China.中国乳腺癌和宫颈癌筛查策略的最优组合建模
BMC Womens Health. 2025 Feb 8;25(1):56. doi: 10.1186/s12905-025-03573-x.
本文引用的文献
1
Breast cancer screening and overdiagnosis.乳腺癌筛查与过度诊断。
Int J Cancer. 2021 Apr 19. doi: 10.1002/ijc.33602.
2
The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.4232名女性原位导管癌（DCIS）分级的分布及其对乳腺癌筛查中过度诊断的影响。
Breast Cancer Res. 2016 May 10;18(1):47. doi: 10.1186/s13058-016-0705-5.
3
The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy.在辅助性全身治疗的情况下，40至50岁开始的基于人群的乳腺钼靶筛查的效果。
Int J Cancer. 2015 Jul 1;137(1):165-72. doi: 10.1002/ijc.29364. Epub 2014 Dec 13.
4
Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet.欧洲乳腺癌服务筛查结果的证据总结以及对收益和危害平衡表的初步评估。
J Med Screen. 2012;19 Suppl 1:5-13. doi: 10.1258/jms.2012.012077.
5
The impact of a breast cancer screening programme on quality-adjusted life-years.乳腺癌筛查项目对质量调整生命年的影响。
Int J Cancer. 1991 Oct 21;49(4):538-44. doi: 10.1002/ijc.2910490411.
Zotero 插件